<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Medical Microbiology</title>
<title_fa>مجله میکروب شناسی پزشکی ایران</title_fa>
<short_title>Iran J Med Microbiol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijmm.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1735-8612</journal_id_issn>
<journal_id_issn_online>2345-4342</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.30699/ijmm</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<volume>19</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>&lt;i&gt;In Silico&lt;/i&gt; Identification of Immunogenic ERv 53-63 Epitope; A Potential Candidate for Tuberculosis Vaccine Design</title>
	<subject_fa>بیوانفورماتیک میکروبی</subject_fa>
	<subject>Microbial Bioinformatics</subject>
	<content_type_fa>مقاله پژوهشی</content_type_fa>
	<content_type>Original Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:16px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;b&gt;&lt;span style=&quot;background:#1f497d&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;&lt;span style=&quot;letter-spacing:-.1pt&quot;&gt;Background and Aim:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span lang=&quot;EN-ID&quot;&gt;&amp;nbsp;Tuberculosis (TB), caused by &lt;em&gt;Mycobacterium (M.) tuberculosis &lt;/em&gt;(MTB), remains a major global health burden and the Bacillus Calmette&amp;ndash;Gu&amp;eacute;rin (BCG) vaccine shows limited efficacy, particularly in adults. This highlights the urgent need for novel vaccine strategies. In silico approaches offer efficient, cost-effective tools for predicting immunogenic epitopes, thereby accelerating peptide-based vaccine development. This study aimed to identify and characterize the ERv 53&amp;ndash;63 epitope, a novel candidate compared to previously studied sequences, as a potential B-cell-targeting epitope for TB vaccine design.&lt;/span&gt;&lt;br&gt;
&lt;b&gt;&lt;span style=&quot;background:#1f497d&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;&lt;span style=&quot;letter-spacing:-.1pt&quot;&gt;Materials and Methods:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &lt;span lang=&quot;EN-ID&quot;&gt;Epitope selection was based on antigenic regions within the ERv protein sequence. ERv 53&amp;ndash;63 was chosen due to higher predicted antigenicity and favorable binding potential. VaxiJen was used for antigenicity assessment, AllerTOP v2.0 for allergenicity, and ToxinPred for toxicity evaluation. Structural docking simulations were conducted using PyMOL, with a human B-cell receptor (PDB ID: 5DRW) as docking target to evaluate epitope&amp;ndash;receptor interaction.&lt;/span&gt;&lt;br&gt;
&lt;b&gt;&lt;span style=&quot;background:#1f497d&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;&lt;span style=&quot;letter-spacing:-.1pt&quot;&gt;Results:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &lt;span lang=&quot;EN-ID&quot;&gt;ERv 53-63 demonstrated high antigenicity (VaxiJen score: 0.9599). It was predicted as non-allergenic and non-toxic, and exhibited strong binding affinity with B-cell receptor (interaction energy: &amp;ndash;877.8 kcal/mol), indicating stable complex formation.&lt;/span&gt;&lt;br&gt;
&lt;b&gt;&lt;span style=&quot;background:#1f497d&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;&lt;span style=&quot;letter-spacing:-.1pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &lt;span lang=&quot;EN-ID&quot;&gt;These findings support ERv 53&amp;ndash;63 as a novel and promising &lt;em&gt;in silico&lt;/em&gt;-derived B-cell epitope, outperforming prior candidates such as ERv 105&amp;ndash;118. It holds strong potential for peptide-based TB vaccine development. Further &lt;em&gt;in vitro&lt;/em&gt; and &lt;em&gt;in vivo&lt;/em&gt; studies are recommended to validate its immunogenicity and safety.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>B-cell Receptor, ERv 53–63 Epitope, In silico, Peptide-based Vaccine, Tuberculosis, Vaccine Design</keyword>
	<start_page>265</start_page>
	<end_page>277</end_page>
	<web_url>http://ijmm.ir/browse.php?a_code=A-10-2718-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Arya Dwi Wijaya</first_name>
	<middle_name></middle_name>
	<last_name>Saputra</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>aryaadityarangga@gmail.com</email>
	<code>100319475328460033258</code>
	<orcid>0009-0006-3500-8928</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biology, UIN Maulana Malik Ibrahim Malang, Malang, Indonesia</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Tharisa Sabrina Ardya</first_name>
	<middle_name></middle_name>
	<last_name>Gharini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>tharisa.sabrina21@gmail.com</email>
	<code>100319475328460033259</code>
	<orcid>100319475328460033259</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biology, UIN Maulana Malik Ibrahim Malang, Malang, Indonesia</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Nadaa Ramadhia</first_name>
	<middle_name></middle_name>
	<last_name>Hariyanto</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>nadaaramadhia.h@gmail.com</email>
	<code>100319475328460033260</code>
	<orcid>100319475328460033260</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biology, UIN Maulana Malik Ibrahim Malang, Malang, Indonesia</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Maharani Retna</first_name>
	<middle_name></middle_name>
	<last_name>Duhita</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>maharaniretna.duhita@uin-malang.ac.id</email>
	<code>100319475328460033261</code>
	<orcid>100319475328460033261</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Biology, UIN Maulana Malik Ibrahim Malang, Malang, Indonesia</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
